10X Genomics Inc (NASDAQ:TXG)
| 62.61 Delayed Data As of Mar 30 |  +2.81 / +4.68%Today’s Change | 45.11 Today|||52-Week Range 108.36 | -17.89% Year-to-Date |
Latest TXG News | Press Releases
No recent news for 10X Genomics Inc.
Today’s Trading
| Previous close | 59.99 |
| Today’s open | 61.16 |
| Day’s range | 58.06 - 63.84 |
| Volume | 418,759 |
| Average volume (3 months) | 388,682 |
| Market cap | $5.8B |
Data as of 3:57pm ET, 03/30/2020
Growth & Valuation
| Earnings growth (last year) | +72.48% |
| Earnings growth (this year) | +41.98% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +68.06% |
| P/E ratio | NM |
| Price/Sales | 29.84 |
| Price/Book | 13.74 |
Competitors
| No competitors data available. |
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | -$0.13 |
| Annual revenue (last year) | $245.9M |
| Annual profit (last year) | -$31.3M |
| Net profit margin | -12.71% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
